Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on June 5, 2006

Circulation. 2006
Published online before print June 5, 2006, doi: 10.1161/CIRCULATIONAHA.105.593558
A more recent version of this article appeared on June 13, 2006
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
113/23/2697    most recent
CIRCULATIONAHA.105.593558v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morita, H.
Right arrow Articles by Benjamin, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morita, H.
Right arrow Articles by Benjamin, E. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
*Genetics Home Reference
Related Collections
Right arrow Hypertrophy
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease
Right arrowRelated Article

Submitted on October 8, 2005
Revised on February 7, 2006
Accepted on March 31, 2006

Single-Gene Mutations and Increased Left Ventricular Wall Thickness in the Community. The Framingham Heart Study

Hiroyuki Morita MD, Martin G. Larson ScD, Scott C. Barr BS, Ramachandran S. Vasan MD, Christopher J. O’Donnell MD, MPH, Joel N. Hirschhorn MD, PhD, Daniel Levy MD, Diane Corey BS, Christine E. Seidman MD, J. G. Seidman PhD*, and Emelia J. Benjamin MD, ScM

From The Program in Genomics Applications: CardioGenomics Group--the Department of Genetics (H.M., S.B., C.E.S., J.G.S.), Massachusetts General Hospital (C.J.O.), and Children’s Hospital (J.N.H.), Harvard Medical School; Boston University School of Medicine, Boston (M.G.L., R.S.V., D.L., E.J.B.); the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Mass (M.G.L., R.S.V., C.J.O., D.L., D.C., E.J.B.); and Massachusetts Institute of Technology, Cambridge, Mass (J.N.H.).

* To whom correspondence should be addressed. E-mail: seidman{at}genetics.med.harvard.edu.

Background--Mutations in sarcomere protein, PRKAG2, LAMP2, {alpha}-galactosidase A (GLA), and several mitochondrial genes can cause rare familial cardiomyopathies, but their contribution to increased left ventricular wall thickness (LVWT) in the community is unknown.

Methods and Results--We studied 1862 unrelated participants (52% women; age, 59±9 years) from the community-based Framingham Heart Study who had echocardiograms and provided DNA samples but did not have severe hypertension, aortic prosthesis, or significant aortic stenosis. Eight sarcomere protein genes, 3 storage cardiomyopathy-causing genes, and 27 mitochondrial genes were sequenced in unrelated individuals with increased LVWT (maximum LVWT >13 mm). Fifty eligible participants (9 women) had unexplained increased LVWT. We detected 8 mutations in 9 individuals (2 women); 7 mutations in 5 sarcomere protein genes (MYH7, MYBPC3, TNNT2, TNNI3, MYL3), and 1 GLA mutation. In individuals with increased LVWT, participants with sarcomere protein and storage mutations were clinically indistinguishable from those without mutations.

Conclusions--In a community-based cohort, about 3% of eligible participants had increased LVWT, of whom 18% had sarcomere protein or lipid storage gene mutations. Increased LVWT in the community is a very heterogeneous condition, which sometimes may arise from single-gene variants in one of a number of genes.


Key words: epidemiology • genetics • hypertrophy • myosin


Related Article:

Issue Highlights
Circulation 2006 113: 2675. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
B. Oqvist, B. M. Brenner, J. P. Oliveira, A. Ortiz, R. Schaefer, E. Svarstad, C. Wanner, K. Zhang, and D. G. Warnock
Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1736 - 1743.
[Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
P. Elliott and W. J. McKenna
How should hypertrophic cardiomyopathy be classified?: Molecular Diagnosis for Hypertrophic Cardiomyopathy: Not Ready for Prime Time
Circ Cardiovasc Genet, February 1, 2009; 2(1): 87 - 89.
[Full Text] [PDF]


Home page
CirculationHome page
P. A. Noseworthy and C. Newton-Cheh
Genetic Determinants of Sudden Cardiac Death
Circulation, October 28, 2008; 118(18): 1854 - 1863.
[Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
C. J. O'Donnell and E. G. Nabel
Cardiovascular Genomics, Personalized Medicine, and the National Heart, Lung, and Blood Institute: Part I: The Beginning of an Era
Circ Cardiovasc Genet, October 1, 2008; 1(1): 51 - 57.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Leatherbury, Q. Yu, B. Chatterjee, D. L. Walker, Z. Yu, X. Tian, and C. W. Lo
A novel mouse model of X-linked cardiac hypertrophy
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2701 - H2711.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. Morita, H. L. Rehm, A. Menesses, B. McDonough, A. E. Roberts, R. Kucherlapati, J. A. Towbin, J.G. Seidman, and C. E. Seidman
Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults
N. Engl. J. Med., May 1, 2008; 358(18): 1899 - 1908.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. K. Arnett and for the Writing Group
Summary of the American Heart Association's Scientific Statement on the Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease
Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1682 - 1686.
[Full Text] [PDF]


Home page
CirculationHome page
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al.
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Circulation, June 5, 2007; 115(22): 2878 - 2901.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Ashrafian and H. Watkins
Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype
J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1251 - 1264.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, June 17, 2006; 332(7555): 1460 - 1460.
[Full Text] [PDF]